A multi-center, multiple dose, open-label, four-cohort, parallel study to assess the pharmacokinetic drug interaction following co-administration of valsartan, hydrochlorothiazide and amlodipine in patients with hypertension
Phase of Trial: Phase III
Latest Information Update: 24 Sep 2010
At a glance
- Drugs Amlodipine; Hydrochlorothiazide; Valsartan
- Indications Hypertension
- Focus Pharmacokinetics
- Sponsors Novartis
- 21 Jul 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 02 Nov 2007 New trial record.